Abstract
Clinical and preclinical findings have suggested a role of the endocannabinoid system (ECS) in the etiopathology of autism spectrum disorder (ASD). Previous mouse studies have investigated the role of ECS in several behavioral domains; however, none of them has performed an extensive assessment of social and communication behaviors, that is, the main core features of ASD. This study employed a mouse line lacking the primary endocannabinoid receptor (CB1r) and characterized ultrasonic communication and social interaction in CB1-/- , CB1+/- , and CB1+/+ males and females. Quantitative and qualitative alterations in ultrasonic vocalizations (USVs) were observed in CB1 null mice both during early development (i.e., between postnatal days 4 and 10), and at adulthood (i.e., at 3 months of age). Adult mutants also showed marked deficits in social interest in the three-chamber test and social investigation in the direct social interaction test. These behavioral alterations were mostly observed in both sexes and appeared more marked in CB1-/- than CB1+/- mutant mice. Importantly, the adult USV alterations could not be attributed to differences in anxiety or sensorimotor abilities, as assessed by the elevated plus maze and auditory startle tests. Our findings demonstrate the role of CB1r in social communication and behavior, supporting the use of the CB1 full knockout mouse in preclinical research on these ASD-relevant core domains. LAY SUMMARY: The endocannabinoid system (ECS) is important for brain development and neural function and is therefore likely to be involved in neurodevelopmental disorders such as Autism Spectrum Disorder (ASD). Here we investigated changes in social behavior and communication, which are core features of ASD, in male and female mice lacking the chief receptor of this system. Our results show that loss of this receptor results in several changes in social behavior and communication both during early development and in adulthood, thus supporting the role of the ECS in these ASD-core behavioral domains.
Keywords: cannabinoid receptor, mouse models, phenotype, sex differences, ultrasounds
© 2021 International Society for Autism Research and Wiley Periodicals LLC.
References
REFERENCES
-
- Assaf, M., Jagannathan, K., Calhoun, V. D., Miller, L., Stevens, M. C., Sahl, R., O’Boyle, J. G., Schultz, R. T., & Pearlson, G. D. (2010). Abnormal functional connectivity of default mode sub-networks in autism spectrum disorder patients. NeuroImage, 53(1), 247-256. https://doi.org/10.1016/j.neuroimage.2010.05.067
-
- Association, A. P. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®).
-
- Bar-Lev Schleider, L., Mechoulam, R., Saban, N., Meiri, G., & Novack, V. (2019). Real life experience of medical cannabis treatment in autism: Analysis of safety and efficacy. Scientific Reports, 9(1), 1-7. https://doi.org/10.1038/s41598-018-37570-y
-
- Barna, I., Zelena, D., Arszovszki, A. C., & Ledent, C. (2004). The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: In vivo and in vitro studies in CB1 receptor knockout mice. Life Sciences, 75(24), 2959-2970. https://doi.org/10.1016/j.lfs.2004.06.006
-
- Baudoin, C., Feron, C., & Magnusson, M. S. (1991). Male-female interactions in staggerer and non-mutant mice: Impairment to react to novelty as a possible explanation of staggerer male social behaviour. Behavioural Processes, 24(1), 49-58. https://doi.org/10.1016/0376-6357(91)90086-F